Clinical trial
Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue…
NCT00476879 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00476879 |
|---|---|
| Title | Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content |
| Official title | Growth Hormone During Fasting. Signaltransduktion in Muscle and Adipose Tissue, Consequence of Growth Hormone Receptor Antagonist, Quantification of Intrahepatic Lipid Content Based on MR Scanning |
| Lead sponsor | University of Aarhus, Other |
| Collaborators | Aarhus University Hospital Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolism, Fatty Liver |
| Intervention type | Drug |
| Interventions | Somatropin and pegvisomant |
| Enrollment | 10 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | May 22, 2007 |
| Last update posted | Aug 12, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: